Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations
The Journal of Physical Chemistry B · 16.04.2026 · 130 (15) · 4105-4116
DOI: 10.1021/acs.jpcb.6c00052 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, online erschienen am 02.04.2026. Verfasst von Hao Lou. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Caffeine, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Office of Integrative Activities.
Abstract (Originalsprache)
Subcutaneous delivery of high-concentration monoclonal antibody (mAb) formulations is increasingly preferred for therapeutic applications but is often hindered by high formulation viscosity. While caffeine has recently been found to be an effective viscosity-reducing agent for some mAbs, such as ipilimumab and infliximab, the detailed molecular mechanism remains unclear. In this study, all-atom molecular dynamics (MD) simulations were employed to elucidate the interactions between caffeine and ipilimumab. The results reveal that hydrophobic effects, rather than electrostatic interactions, primarily drive the preferential inclusion of caffeine onto ipilimumab. Trajectory analysis identified 38 high-frequency caffeine-contact residues, some of which, such as TRP101 in the Fab heavy chain, overlap with some "hot spot" residues responsible for Fab-Fab interaction. It is hypothesized that caffeine reduces formulation viscosity by shielding these residues and thereby weakening mAb reversible self-association. The conformational analysis based on K-means clustering suggested that, in the presence of caffeine, the conformations of both the Fab and Fc fragments became more rigid without a significant change in the overall mAb compactness. These findings provide molecular-level insights into the potential use of caffeine as a new viscosity-reducing agent for high-concentration mAb formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.
ORCID-Profile: Hao Lou
Förderung
- Office of Integrative Activities
Zitieren
APA
Lou, H. (2026). Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations. The Journal of Physical Chemistry B, 130(15), 4105-4116. https://doi.org/10.1021/acs.jpcb.6c00052
Vancouver
Lou H. Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations. The Journal of Physical Chemistry B. 2026;130(15):4105-4116. doi:10.1021/acs.jpcb.6c00052
BibTeX
@article{Lou2026,
author = {Lou, Hao},
title = {Caffeine as a Viscosity-Reducing Agent for High-Concentration mAb Formulations: Insights from Molecular Dynamics Simulations},
journal = {The Journal of Physical Chemistry B},
year = {2026},
volume = {130},
number = {15},
pages = {4105--4116},
doi = {10.1021/acs.jpcb.6c00052}
}
EUVIMED